CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 107 enrolled
Drug / intervention
Mindfulness Based Stress Reduction +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03998462
NCT03998462N/ACompleted

Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study

VA Office of Research and Development·interventional·Posted Jun 26, 2019·Updated Nov 18, 2025

In Brief

A clinical study evaluating Mindfulness Based Stress Reduction and Psychoeducational Supportive Care for Parkinson's Disease. Completed, enrolled 107 participants across 1 site.

Detailed Summary

To investigate the efficacy of Mindfulness-based Stress Reduction (MBSR) to improve quality of life, cognition, and mood, as well as to determine the longevity of the treatment response in individuals with Parkinson's disease (PD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 26, 2019
Enrollment StartJan 1, 2020
Primary CompletionNov 1, 2024
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 7.0 years ago

Interventions

Mindfulness Based Stress Reductionbehavioral

MBSR used in this trial was based on the standard program developed by Jon Kabat-Zinn (1990). It consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour retreat during week 7. Due to the COVID-19 pandemic, the MBSR sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.

Psychoeducational Supportive Carebehavioral

PSC is a novel intervention developed by Schiehser and colleagues to provide psychoeducation about Parkinson's disease and supportive group care. PSC consisted of weekly 2.5 hours sessions x 8 weeks and one 4-hour "retreat" during week 7. Due to the COVID-19 pandemic, all sessions were conducted completely online with randomized groups of 6-9 individuals with PD and were led by a trained instructor who was not involved in the clinical care or assessment of the participants.